Lithium continuation therapy following electroconvulsive therapy. 1981

A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond

Thirty-eight depressed patients who were treated with ECT were randomly assigned to receive lithium therapy or identical-looking placebo tablets for one year after clinical recovery in a double-blind trial. The patients who received placebo tablets spent an average of 7.8 weeks with an episode of depression (either as in-patients or day-patients) during the year. In comparison, patients who received lithium spent on average 1.7 weeks with an episode (P less than 0.02). The trial confirms the high rate of relapses after ECT and suggests that lithium considerably reduces this morbidity. It is suggested that ECT without continuation therapy is not a satisfactory treatment of depressive illness.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
December 2011, The journal of ECT,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
December 2021, Ugeskrift for laeger,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
June 1995, Convulsive therapy,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
January 1989, Convulsive therapy,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
October 1990, Journal of clinical psychopharmacology,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
September 2008, The journal of ECT,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
November 2005, Der Nervenarzt,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
December 2021, Asian journal of psychiatry,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
June 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
A Coppen, and M T Abou-Saleh, and P Milln, and J Bailey, and M Metcalfe, and B H Burns, and A Armond
June 2015, The journal of ECT,
Copied contents to your clipboard!